Caitong International Asset Management Co., LTD Ascendis Pharma A/S Transaction History
Caitong International Asset Management Co., LTD
- $134 Billion
- Q1 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 284 shares of ASND stock, worth $48,910. This represents 0.03% of its overall portfolio holdings.
Number of Shares
284
Previous 268
5.97%
Holding current value
$48,910
Previous $36.9 Million
19.97%
% of portfolio
0.03%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding ASND
# of Institutions
270Shares Held
61.9MCall Options Held
151KPut Options Held
226K-
Ra Capital Management, L.P. Boston, MA10.3MShares$1.77 Billion33.28% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.48MShares$944 Million4.42% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.22MShares$899 Million13.16% of portfolio
-
Janus Henderson Group PLC London, X04.49MShares$773 Million0.4% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.26MShares$733 Million1.14% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $9.61B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...